My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 2341

    1.

    Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity.

    Tenbusch M, Kuate S, Tippler B, Gerlach N, Schimmer S, Dittmer U, Uberla K.

    BMC Immunol. 2008 Apr 11;9:13.PMID: 18405363 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

    Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K.

    BMC Immunol. 2009 Aug 3;10:43.PMID: 19650904 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.

    Pinto AR, Fitzgerald JC, Giles-Davis W, Gao GP, Wilson JM, Ertl HC.

    J Immunol. 2003 Dec 15;171(12):6774-9.PMID: 14662882 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.

    Kumar S, Villinger F, Oakley M, Aguiar JC, Jones TR, Hedstrom RC, Gowda K, Chute J, Stowers A, Kaslow DC, Thomas EK, Tine J, Klinman D, Hoffman SL, Weiss WW.

    Immunol Lett. 2002 Apr 1;81(1):13-24.PMID: 11841841 [PubMed - indexed for MEDLINE]Related articles

    5.

    A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF).

    Lima J, Jenkins C, Guerrero A, Triozzi PL, Shaw DR, Strong TV.

    Vaccine. 2005 Jan 26;23(10):1273-83.PMID: 15652670 [PubMed - indexed for MEDLINE]Related articles

    6.

    Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.

    Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.

    Cancer Res. 2001 Nov 1;61(21):7925-33.PMID: 11691814 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine.

    Chang EY, Chen CH, Ji H, Wang TL, Hung K, Lee BP, Huang AY, Kurman RJ, Pardoll DM, Wu T.

    Int J Cancer. 2000 Jun 1;86(5):725-30.PMID: 10797297 [PubMed - indexed for MEDLINE]Related articles

    8.

    Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways.

    Rush C, Mitchell T, Garside P.

    J Immunol. 2002 Nov 1;169(9):4951-60.PMID: 12391208 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.

    Chavan R, Marfatia KA, An IC, Garber DA, Feinberg MB.

    J Virol. 2006 Aug;80(15):7676-87.PMID: 16840346 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens.

    Schirmbeck R, Reimann J, Kochanek S, Kreppel F.

    Mol Ther. 2008 Sep;16(9):1609-16. Epub 2008 Jul 8.PMID: 18612271 [PubMed - indexed for MEDLINE]Related articles

    11.

    Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.

    Bowne WB, Wolchok JD, Hawkins WG, Srinivasan R, Gregor P, Blachere NE, Moroi Y, Engelhorn ME, Houghton AN, Lewis JJ.

    Cytokines Cell Mol Ther. 1999 Dec;5(4):217-25.PMID: 10850386 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cytokine GM-CSF genetic adjuvant facilitates prophylactic DNA vaccine against pseudorabies virus through enhanced immune responses.

    Yoon HA, Aleyas AG, George JA, Park SO, Han YW, Lee JH, Cho JG, Eo SK.

    Microbiol Immunol. 2006;50(2):83-92.PMID: 16490926 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.

    Buchan S, Grønevik E, Mathiesen I, King CA, Stevenson FK, Rice J.

    J Immunol. 2005 May 15;174(10):6292-8.PMID: 15879128 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?

    Hoffman SL, Doolan DL.

    Dev Biol (Basel). 2000;104:121-32.PMID: 11713810 [PubMed - indexed for MEDLINE]Related articles

    15.

    Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.

    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.

    Cancer Res. 2000 Mar 15;60(6):1663-70.PMID: 10749137 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.

    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.

    Eur J Immunol. 2009 Oct;39(10):2725-36.PMID: 19637230 [PubMed - indexed for MEDLINE]Related articles

    17.

    Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.

    Barouch DH, Santra S, Tenner-Racz K, Racz P, Kuroda MJ, Schmitz JE, Jackson SS, Lifton MA, Freed DC, Perry HC, Davies ME, Shiver JW, Letvin NL.

    J Immunol. 2002 Jan 15;168(2):562-8.PMID: 11777947 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.

    Rowe HM, Lopes L, Ikeda Y, Bailey R, Barde I, Zenke M, Chain BM, Collins MK.

    Mol Ther. 2006 Feb;13(2):310-9. Epub 2005 Nov 4.PMID: 16275163 [PubMed - indexed for MEDLINE]Related articles

    19.

    A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.

    Weiss WR, Ishii KJ, Hedstrom RC, Sedegah M, Ichino M, Barnhart K, Klinman DM, Hoffman SL.

    J Immunol. 1998 Sep 1;161(5):2325-32.PMID: 9725227 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.

    Marincek BC, Kühnle MC, Srokowski C, Schild H, Hämmerling G, Momburg F.

    Mol Immunol. 2008 Nov;46(1):181-91. Epub 2008 Sep 18.PMID: 18804283 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity